Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE52.7700
- TODAY'S CHANGE (%)-0.2200 (-0.4152%)
- Bid / Lots47.9100/ 1
- Ask / Lots55.9000/ 1
- Open / Previous Close53.2400 / 52.9900
- Day Range
- 52 Week Range
- Volume781,790
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 5218 | 53.24 |
| 09:38 ET | 100 | 53.7 |
| 09:39 ET | 438 | 53.69 |
| 09:41 ET | 638 | 53.67 |
| 09:43 ET | 300 | 53.615 |
| 09:45 ET | 400 | 53.6 |
| 09:48 ET | 200 | 53.57 |
| 09:50 ET | 600 | 53.5 |
| 09:52 ET | 901 | 53.61 |
| 09:54 ET | 939 | 53.635 |
| 09:56 ET | 833 | 53.9 |
| 09:57 ET | 2754 | 53.595 |
| 09:59 ET | 312 | 53.59 |
| 10:01 ET | 300 | 53.57 |
| 10:03 ET | 575 | 53.555 |
| 10:06 ET | 840 | 53.525 |
| 10:08 ET | 1200 | 53.475 |
| 10:10 ET | 2518 | 53.265 |
| 10:14 ET | 1913 | 53.205 |
| 10:15 ET | 1865 | 53.195 |
| 10:17 ET | 1803 | 53.21 |
| 10:19 ET | 341 | 53.2 |
| 10:21 ET | 2011 | 53.24 |
| 10:24 ET | 2197 | 53.53 |
| 10:26 ET | 137 | 53.535 |
| 10:28 ET | 1232 | 53.55 |
| 10:30 ET | 100 | 53.51 |
| 10:32 ET | 1038 | 53.535 |
| 10:33 ET | 176 | 53.53 |
| 10:35 ET | 1642 | 53.49 |
| 10:37 ET | 500 | 53.44 |
| 10:39 ET | 372 | 53.51 |
| 10:42 ET | 300 | 53.59 |
| 10:44 ET | 1145 | 53.545 |
| 10:46 ET | 100 | 53.545 |
| 10:50 ET | 300 | 53.53 |
| 10:53 ET | 600 | 53.5 |
| 10:55 ET | 500 | 53.545 |
| 11:00 ET | 1300 | 53.595 |
| 11:02 ET | 4027 | 53.47 |
| 11:04 ET | 900 | 53.55 |
| 11:08 ET | 989 | 53.57 |
| 11:09 ET | 6299 | 53.54 |
| 11:11 ET | 200 | 53.33 |
| 11:13 ET | 200 | 53.325 |
| 11:18 ET | 600 | 53.28 |
| 11:20 ET | 100 | 53.33 |
| 11:22 ET | 4049 | 53.2 |
| 11:24 ET | 500 | 53.075 |
| 11:26 ET | 200 | 53.015 |
| 11:27 ET | 714 | 52.9 |
| 11:29 ET | 1020 | 52.915 |
| 11:31 ET | 200 | 52.82 |
| 11:38 ET | 300 | 52.81 |
| 11:40 ET | 300 | 52.74 |
| 11:42 ET | 400 | 52.63 |
| 11:44 ET | 100 | 52.5 |
| 11:47 ET | 400 | 52.485 |
| 11:49 ET | 984 | 52.43 |
| 11:51 ET | 400 | 52.35 |
| 11:56 ET | 1906 | 52.43 |
| 11:58 ET | 500 | 52.38 |
| 12:00 ET | 400 | 52.3 |
| 12:02 ET | 3404 | 52.2 |
| 12:03 ET | 400 | 52.23 |
| 12:05 ET | 456 | 52.165 |
| 12:07 ET | 200 | 52.145 |
| 12:09 ET | 951 | 52.285 |
| 12:12 ET | 1060 | 52.42 |
| 12:14 ET | 400 | 52.41 |
| 12:18 ET | 200 | 52.36 |
| 12:20 ET | 100 | 52.33 |
| 12:23 ET | 100 | 52.335 |
| 12:25 ET | 500 | 52.25 |
| 12:27 ET | 600 | 52.28 |
| 12:30 ET | 100 | 52.3 |
| 12:34 ET | 100 | 52.23 |
| 12:38 ET | 562 | 52.315 |
| 12:39 ET | 1694 | 52.38 |
| 12:41 ET | 600 | 52.26 |
| 12:43 ET | 200 | 52.26 |
| 12:45 ET | 200 | 52.275 |
| 12:48 ET | 500 | 52.2 |
| 12:50 ET | 461 | 52.25 |
| 12:52 ET | 2216 | 52.13 |
| 12:56 ET | 1200 | 52.215 |
| 12:59 ET | 382 | 52.335 |
| 01:03 ET | 508 | 52.31 |
| 01:06 ET | 100 | 52.26 |
| 01:12 ET | 100 | 52.275 |
| 01:14 ET | 400 | 52.31 |
| 01:15 ET | 500 | 52.22 |
| 01:26 ET | 700 | 52.25 |
| 01:28 ET | 300 | 52.245 |
| 01:30 ET | 200 | 52.245 |
| 01:32 ET | 400 | 52.2 |
| 01:33 ET | 1274 | 52.33 |
| 01:35 ET | 500 | 52.26 |
| 01:39 ET | 300 | 52.265 |
| 01:42 ET | 100 | 52.245 |
| 01:44 ET | 1100 | 52.11 |
| 01:46 ET | 200 | 52.205 |
| 01:48 ET | 200 | 52.17 |
| 01:50 ET | 303 | 52.15 |
| 01:51 ET | 325 | 52.13 |
| 01:53 ET | 700 | 52.17 |
| 01:55 ET | 200 | 52.23 |
| 01:57 ET | 300 | 52.21 |
| 02:00 ET | 100 | 52.22 |
| 02:02 ET | 1100 | 52.65 |
| 02:04 ET | 850 | 53.315 |
| 02:06 ET | 11237 | 53.485 |
| 02:08 ET | 1400 | 53.45 |
| 02:09 ET | 15928 | 53.1 |
| 02:11 ET | 5509 | 53.1475 |
| 02:13 ET | 1931 | 52.96 |
| 02:15 ET | 2328 | 53.19 |
| 02:18 ET | 1062 | 53.48 |
| 02:20 ET | 2823 | 53.485 |
| 02:22 ET | 2699 | 53.52 |
| 02:24 ET | 1100 | 53.52 |
| 02:26 ET | 300 | 53.61 |
| 02:27 ET | 564 | 53.5 |
| 02:29 ET | 1279 | 53.585 |
| 02:31 ET | 1700 | 53.6 |
| 02:33 ET | 400 | 53.675 |
| 02:36 ET | 2486 | 53.675 |
| 02:38 ET | 2253 | 53.48 |
| 02:40 ET | 600 | 53.7 |
| 02:42 ET | 700 | 53.62 |
| 02:44 ET | 1803 | 53.35 |
| 02:45 ET | 2124 | 52.9 |
| 02:47 ET | 2213 | 53.245 |
| 02:49 ET | 1000 | 53.23 |
| 02:51 ET | 341 | 53.36 |
| 02:54 ET | 1948 | 53.67 |
| 02:56 ET | 700 | 53.63 |
| 02:58 ET | 500 | 53.82 |
| 03:00 ET | 1100 | 53.37 |
| 03:02 ET | 1636 | 53.2 |
| 03:03 ET | 2469 | 52.94 |
| 03:05 ET | 465 | 53.07 |
| 03:07 ET | 1280 | 52.925 |
| 03:09 ET | 400 | 53.03 |
| 03:12 ET | 1500 | 52.9 |
| 03:14 ET | 2741 | 53.31 |
| 03:16 ET | 200 | 53.52 |
| 03:18 ET | 900 | 53.38 |
| 03:20 ET | 677 | 53.36 |
| 03:21 ET | 1902 | 53 |
| 03:23 ET | 2904 | 52.96 |
| 03:25 ET | 1787 | 53.15 |
| 03:27 ET | 1300 | 53.41 |
| 03:30 ET | 1300 | 53.39 |
| 03:32 ET | 2028 | 53.31 |
| 03:34 ET | 1211 | 53.37 |
| 03:36 ET | 1591 | 53.26 |
| 03:38 ET | 2600 | 53.14 |
| 03:39 ET | 1900 | 53.38 |
| 03:41 ET | 1658 | 53.34 |
| 03:43 ET | 1502 | 53.33 |
| 03:45 ET | 3740 | 53.135 |
| 03:48 ET | 2988 | 53.005 |
| 03:50 ET | 400 | 52.96 |
| 03:52 ET | 4184 | 53.08 |
| 03:54 ET | 4339 | 53.08 |
| 03:56 ET | 5626 | 53.145 |
| 03:57 ET | 6596 | 52.89 |
| 03:59 ET | 359746 | 52.77 |
Sep 16, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $90.00/Share by Cantor Fitzgerald, from 11:46AM ET on Monday Sep 16, 2024 by Dow Jones
11:46AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 10, 2024
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:40PM ET on Tuesday Sep 10, 2024 by Dow Jones
4:40PM ET on Tuesday Sep 10, 2024 by Dow Jones
Aug 29, 2024
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences, from 4:05PM ET on Thursday Aug 29, 2024 by Dow Jones
4:05PM ET on Thursday Aug 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.2B | -14.0x | --- |
Immunovant Inc | 4.3B | -15.1x | --- |
Biohaven Ltd | 3.7B | -4.3x | --- |
Avidity Biosciences Inc | 4.9B | -15.1x | --- |
Arcellx Inc | 4.2B | -76.6x | --- |
Dyne Therapeutics Inc | 3.5B | -9.6x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2B |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 80.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.64 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -14.0x |
Price/Sales (TTM) | 3,062.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20,068.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
